Search results
Results from the Health.Zone Content Network
McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 51,000 employees.
Change Healthcare Inc. Change Healthcare Inc. (known as Emdeon before rebranding in 2015, which followed its acquisition of Change Healthcare) is a provider of revenue and payment cycle management that connects payers, providers, and patients within the U.S. healthcare system. The name also refers to a company founded in 2007 which subsequently ...
John Hammergren. (1959-02-20) 20 February 1959 (age 65) Saint Paul, Minnesota, U.S. Occupation (s) CEO of McKesson Corporation, Retired. John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. [1] On November 1, 2018, Hammergren announced his plan to retire. [2]
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...
SAN FRANCISCO--(BUSINESS WIRE)-- McKesson Corporation (NYS: MCK) announced that today it completed the previously announced acquisition of PSS World Medical, Inc. for a total purchase price of ...
On Wednesday, health-care services and IT firm McKesson Corporation (NYS: MCK) confirmed it has received notification of the early termination of the Hart-Scott-Rodino waiting period required ...
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and ...
McKesson Reports Fiscal 2013 Fourth-Quarter and Full-Year Results Revenues of $30.6 billion for the fourth quarter and $122.5 billion for the full year. Fourth-quarter GAAP earnings per diluted ...